| [12] |
Kamezaki C,Nakashima A,Yamada A, et al. Synergistic antioxidative effect of astaxanthin and tocotrienol by co-encapsulated in liposomes[J]. J Clin Biochem Nutr, 2016, 59(2): 100-106.
|
| [13] |
Yuan JP,Chen F. Hydrolysis kinetics of astaxanthin esters and stability of astaxanthin of haematococcus pluvialis during saponification[J]. J Agric Food Chem, 1999, 47(1): 31-35.
|
| [14] |
Albulishi MSM,Changhu X,Tang QJ. Health aspects of astaxanthin: a review[J]. Canad J Clin Nutr, 2015, 3(2): 71-78.
|
| [15] |
Guerin M,Huntley ME,Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition[J]. Trends Biotechnol, 2003, 21(5): 210-216.
|
| [16] |
Régnier P,Bastias J,Rodriguez-Ruiz V, et al. Astaxanthin from haematococcus pluvialis prevents oxidative stress on human endothelial cells without toxicity[J]. Mar Drugs, 2015, 13(5): 2857-2874.
|
| [17] |
Moran NE,Mohn ES,Hason N, et al. Intrinsic and extrinsic factors impacting absorption, metabolism, and health effects of dietary carotenoids[J]. Adv Nutr, 2018, 9(4): 465-492.
|
| [18] |
Viera I,Pérez-Gálvez A,Roca M. Bioaccessibility of marine carotenoids[J]. Mar Drugs, 2018, 16(10). pii: E397.
|
| [19] |
Ranga Rao A,Raghunath Reddy RL,Baskaran V, et al. Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat model[J]. J Agric Food Chem, 2010, 58(15): 8553-8559.
|
| [20] |
Stewart JS,Lignell A,Pettersson A, et al. Safety assessment of astaxanthin-rich microalgae biomass: acute and subchronic toxicity studies in rats[J]. Food Chem Toxicol, 2008, 46(9): 3030-3036.
|
| [21] |
Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential[J]. Altern Med Rev, 2011, 16(4): 355-364.
|
| [22] |
Hiebert JB,Shen Q,Thimmesch AR, et al. Traumatic brain injury and mitochondrial dysfunction[J]. Am J Med Sci, 2015, 350(2): 132-138.
|
| [23] |
Khatri N,Thakur M,Pareek V, et al. Oxidative stress: major threat in traumatic brain injury[J]. CNS Neurol Disord Drug Targets, 2018, 17(9): 689-695.
|
| [24] |
Lee DH,Kim CS,Lee YJ. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro[J]. Food Chem Toxicol, 2011, 49(1): 271-280.
|
| [25] |
Augusti PR,Quatrin A,Somacal S, et al. Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits[J]. J Clin Biochem Nutr, 2012, 51(1): 42-49.
|
| [26] |
Saw CL,Yang AY,Guo Y, et al. Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway[J]. Food Chem Toxicol, 2013, 62: 869-875.
|
| [27] |
Zolnourian A,Galea I,Bulters D. Neuroprotective role of the Nrf2 pathway in subarachnoid haemorrhage and its therapeutic potential[J]. Oxid Med Cell Longev, 2019, 2019: 6218239.
|
| [28] |
Kim JH,Choi W,Lee JH, et al. Astaxanthin inhibits H2O2-mediated apoptotic cell death in mouse neural progenitor cells via modulation of P38 and MEK signaling pathways[J]. J Microbiol Biotechnol, 2009, 19(11): 1355-1363.
|
| [29] |
Balietti M,Giannubilo SR,Giorgetti B, et al. The effect of astaxanthin on the aging rat brain: gender-related differences in modulating inflammation[J]. J Sci Food Agric, 2016, 96(2): 615-618.
|
| [30] |
Zhang XS,Zhang X,Wu Q, et al. Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage[J]. J Surg Res, 2014, 192(1): 206-213.
|
| [31] |
Wen X,Xiao L,Zhong Z, et al. Astaxanthin acts via LRP-1 to inhibit inflammation and reverse lipopolysaccharide-induced M1/M2 polarization of microglial cells[J]. Oncotarget, 2017, 8(41): 69370-69385.
|
| [32] |
Laird MD,Sukumari-Ramesh S,Swift AE, et al. Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?[J]. J Neurochem, 2010, 113(3): 637-648.
|
| [33] |
Hui H,Rao W,Zhang L, et al. Inhibition of Na(+)-K(+)-2Cl(-) cotransporter-1 attenuates traumatic brain injury-induced neuronal apoptosis via regulation of Erk signaling[J]. Neurochem Int, 2016, 94: 23-31.
|
| [34] |
Zhang M,Cui Z,Cui H, et al. Astaxanthin alleviates cerebral edema by modulating NKCC1 and AQP4 expression after traumatic brain injury in mice[J]. BMC Neurosci, 2016, 17(1): 60.
|
| [35] |
Zhang M,Cui Z,Cui H. Astaxanthin protects astrocytes against trauma-induced apoptosis through inhibition of NKCC1 expression via the NF-κB signaling pathway[J]. BMC Neurosci, 2017, 18(1): 42.
|
| [36] |
Acosta SA,Tajiri N,de la Pena I, et al. Alpha-synuclein as a pathological link between chronic traumatic brain injury and parkinson's disease[J]. J Cell Physiol, 2015, 230(5): 1024-1032.
|
| [37] |
Dams-O’Connor K,Guetta G,Hahn-Ketter AE, et al. Traumatic brain injury as a risk factor for alzheimer’s disease: current knowledge and future directions[J]. Neurodegener Dis Manag, 2016, 6(5): 417-429.
|
| [38] |
Emmerling MR,Morganti-Kossmann MC,Kossmann T, et al. Traumatic brain injury elevates the alzheimer’s amyloid peptide a beta 42 in human CSF. A possible role for nerve cell injury[J]. Ann N Y Acad Sci, 2000, 903: 118-122.
|
| [39] |
Nakagawa K,Kiko T,Miyazawa T, et al. Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes[J]. Br J Nutr, 2011, 105(11): 1563-1571.
|
| [40] |
Wu H,Niu H,Shao A, et al. Astaxanthin as a potential neuroprotective agent for neurological diseases[J]. Mar Drugs, 2015, 13(9): 5750-5766.
|
| [41] |
Manabe Y,Komatsu T,Seki S, et al. Dietary astaxanthin can accumulate in the brain of rats[J]. Biosci Biotechnol Biochem, 2018, 82(8): 1433-1436.
|
| [1] |
Salehi A,Zhang JH,Obenaus A. Response of the cerebral vasculature following traumatic brain injury[J]. J Cereb Blood Flow Metab, 2017, 37(7): 2320-2339.
|
| [2] |
Sorby-Adams AJ,Marcoionni AM,Dempsey ER, et al. The role of neurogenic inflammation in blood-brain barrier disruption and development of cerebral oedema following acute central nervous system (CNS) injury[J]. Int J Mol Sci, 2017, 18(8). pii: E1788.
|
| [3] |
Nikolian VC,Dekker SE,Bambakidis T, et al. Improvement of blood-brain barrier integrity in traumatic brain injury and hemorrhagic shock following treatment with valproic acid and fresh frozen plasma[J]. Crit Care Med, 2018, 46(1): e59-e66.
|
| [4] |
Langlois JA,Rutland-Brown W,Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview[J]. J Head Trauma Rehabil, 2006, 21(5): 375-378.
|
| [5] |
Mioni G,Grondin S,Stablum F. Temporal dysfunction in traumatic brain injury patients: primary or secondary impairment?[J]. Front Hum Neurosci, 2014, 8: 269.
|
| [6] |
Maas AIR,Menon DK,Adelson PD, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research[J]. Lancet Neurol, 2017, 16(12): 987-1048.
|
| [42] |
Wen X,Huang A,Hu J, et al. Neuroprotective effect of astaxanthin against glutamate-induced cytotoxicity in HT22 cells: involvement of the Akt/GSK-3β pathway[J]. Neuroscience, 2015, 303: 558-568.
|
| [43] |
Fakhri S,Aneva IY,Farzaei MH, et al. The neuroprotective effects of astaxanthin: therapeutic targets and clinical perspective[J]. Molecules, 2019, 24(14). pii: E2640.
|
| [7] |
Fassett RG,Coombes JS. Astaxanthin: a potential therapeutic agent in cardiovascular disease[J]. Mar Drugs, 2011, 9(3): 447-465.
|
| [8] |
Zhang J,Sun Z,Sun P, et al. Microalgal carotenoids: beneficial effects and potential in human health[J]. Food Funct, 2014, 5(3): 413-425.
|
| [9] |
Grimmig B,Kim SH,Nash K, et al. Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration[J]. Geroscience, 2017, 39(1): 19-32.
|
| [10] |
Ji X,Peng D,Zhang Y, et al. Astaxanthin improves cognitive performance in mice following mild traumatic brain injury[J]. Brain Res, 2017, 1659: 88-95.
|
| [11] |
Ambati RR,Phang SM,Ravi S, et al. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review[J]. Mar Drugs, 2014, 12(1): 128-152.
|